Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan in Pediatric Acute Heart Failure
NCT01301313Phase 2Terminated
- Start
- Feb 2011
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levosimendan in Acute Heart Failure (AHF). Started Feb 2011; status: terminated.
02
Drugs
levosimendan
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on NCT01301313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01301313.